Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Wilkinson, Tom M, Li, Chris K F, Chui, Cecilia S C, Huang, Arthur K Y, Perkins, Molly, Liebner, Julia C, Lambkin-Williams, Rob, Gilbert, Anthony +7 more·2012·Nature Medicine

Cited by (982)

Items 101–200 of 982

  1. Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
    Stéphane Pillet, Julie Couillard, Sonia Trépanier, Jean‐François Poulin, Bader Yassine‐Diab, Bruno Guy, Brian J. Ward, Nathalie Landry · 2019 · PLoS ONE
  2. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
    Diletta Magini, Cinzia Giovani, Simona Mangiavacchi, Silvia Maccari, Raffaella Cecchi, Jeffrey B. Ulmer, Ennio De Gregorio, Andrew J. Geall, Michela Brazzoli, Sylvie Bertholet · 2016 · PLoS ONE
  3. Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research
    Jill M. Ferdinands, Mark G. Thompson, Lenee Blanton, Sarah Spencer, Lauren Grant, Alicia M. Fry · 2021 · Vaccine
  4. COVID-19: Mechanisms of Vaccination and Immunity
    Daniel E. Speiser, Martin F. Bachmann · 2020 · Vaccines
  5. Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease
    Zhongfang Wang, Lingyan Zhu, Thi H. O. Nguyen, Yanmin Wan, Sneha Ashok Sant, Sergio M. Quiñones‐Parra, Jeremy Chase Crawford, Auda A. Eltahla, Simone Rizzetto, Rowena Anne Bull et al. · 2018 · Nature Communications
  6. Cytokine-Dependent Induction of CD4+T cells with Cytotoxic Potential during Influenza Virus Infection
    Laiqing Hua, Shuyu Yao, Duy Pham, Li Jiang, Jeffrey Wright, Deepali V. Sawant, Alexander L. Dent, Thomas J. Braciale, Mark H. Kaplan, Jie Sun · 2013 · Journal of Virology
  7. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
    Angelika Wagner, Birgit Weinberger · 2020 · Frontiers in Immunology
  8. Dynamics of Lung Defense in Pneumonia: Resistance, Resilience, and Remodeling
    Lee J. Quinton, Joseph P. Mizgerd · 2014 · Annual Review of Physiology
  9. Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
    E. Bridie Clemens, Carolien E. van de Sandt, Sook‐San Wong, Linda M. Wakim, Sophie A. Valkenburg · 2018 · Vaccines
  10. Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future
    Claudia Maria Trombetta, Daniele Perini, Stuart T. Mather, Nigel James Temperton, Emanuele Montomoli · 2014 · Vaccines
  11. Swine as a Model for Influenza A Virus Infection and Immunity
    Daniela S. Rajão, Amy Louise Vincent · 2015 · ILAR Journal
  12. Respiratory Infection and the Impact of Pulmonary Immunity on Lung Health and Disease
    Joseph P. Mizgerd · 2012 · American Journal of Respiratory and Critical Care Medicine
  13. Human circulating and tissue-resident memory CD8+ T cells
    Marcus Buggert, David A. Price, Laura K. Mackay, Michael R. Betts · 2023 · Nature Immunology
  14. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
    Christopher S. Ambrose, Xionghua Wu, Taff Jones, Raburn M. Mallory · 2012 · Vaccine
  15. Development of a Universal Influenza Vaccine
    Leonardo D. Estrada, Stacey Schultz‐Cherry · 2019 · The Journal of Immunology
  16. Association of HLA-DRB1–restricted CD4+ T cell responses with HIV immune control
    Srin Ranasinghe, Sam Cutler, Isaiah Davis, Richard Lu, Damien Z. Soghoian, Ying Qi, John Sidney, Gregory Kranias, Michael Flanders, Madelene Lindqvist et al. · 2013 · Nature Medicine
  17. The Emergence and Functional Fitness of Memory CD4+ T Cells Require the Transcription Factor Thpok
    Thomas Ciucci, Melanie S. Vacchio, Yayi Gao, Francesco Tomassoni‐Ardori, Julián Candia, Monika Mehta, Yongmei Zhao, Bao Quoc Tran, Marion Pepper, Lino Tessarollo et al. · 2019 · Immunity
  18. Clonally expanded cytotoxic CD4 + T cells and the pathogenesis of IgG4-related disease
    Hamid Mattoo, John H. Stone, Shiv S Pillai · 2017 · Autoimmunity
  19. Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia
    Nicole M.S. Smith, Gregory A. Wasserman, Fadie T. Coleman, Kristie L. Hilliard, Kazuko Yamamoto, E Lipsitz, Richard Malley, Hans Dooms, Matthew R. Jones, Lee J. Quinton et al. · 2017 · Mucosal Immunology
  20. T cell immunity to SARS-CoV-2 following natural infection and vaccination
    Anthony T. DiPiazza, Barney S. Graham, Tracy J. Ruckwardt · 2020 · Biochemical and Biophysical Research Communications
  21. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
    David Gordon, Dimitar Sajkov, Richard John Woodman, Yoshikazu Honda‐Okubo, Manon M. J. Cox, Susanne Heinzel, Nikolai Petrovsky · 2012 · Vaccine
  22. Mucosal Vaccine Development Based on Liposome Technology
    Valentina Bernasconi, Karin Norling, Marta Bally, Fredrik Höök, Nils Yngve Lycke · 2016 · Journal of Immunology Research
  23. Immunity to viruses: learning from successful human vaccines
    Bali Pulendran, Jason Z. Oh, Helder Imoto Nakaya, Rajesh Ravindran, Dmitri A. Kazmin · 2013 · Immunological Reviews
  24. Corticosteroid administration for viral pneumonia: COVID-19 and beyond
    Jia‐Wei Yang, Li Yang, R.-G. Luo, Jin‐Fu Xu · 2020 · Clinical Microbiology and Infection
  25. Influenza in Children
    Jennifer Lynn Nayak, Gregory E. Hoy, Aubree L. Gordon · 2019 · Cold Spring Harbor Perspectives in Medicine
  26. Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
    Richard Antrobus, Tamara Katherine Berthoud, Caitlin E. Mullarkey, Katja Höschler, Lynda Coughlan, Maria Cristina Fleischmann Alves Zambon, Adrian V. S. Hill, Sarah C. Gilbert · 2013 · Molecular Therapy
  27. The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics
    Demetra S.M. Chatzileontiadou, Hannah Sloane, Andrea Nguyen, Stéphanie Gras, Emma J. Grant · 2020 · International Journal of Molecular Sciences
  28. Immunosenescence and Novel Vaccination Strategies for the Elderly
    Michael G. Dorrington, Dawn M. E. Bowdish · 2013 · Frontiers in Immunology
  29. Cell culture-based influenza vaccines: A necessary and indispensable investment for the future
    Nagendra R. Hegde · 2015 · Human Vaccines & Immunotherapeutics
  30. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
    Saranya Sridhar · 2016 · Frontiers in Immunology
  31. Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice
    Kirsi Tamminen, Suvi Lappalainen, Leena Huhti, Timo Vesikari, Vesna Blazevic · 2013 · PLoS ONE
  32. Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease
    Anshu P. Gounder, Adrianus C. M. Boon · 2019 · The Journal of Immunology
  33. Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification
    Ashley Sobel Leonard, Micah T. McClain, Gavin J. D. Smith, David E. Wentworth, Rebecca Halpin, Xudong Lin, Amy Ransier, Timothy B. Stockwell, Suman R. Das, Anthony S. Gilbert et al. · 2016 · Journal of Virology
  34. Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection
    Yuan Tian, Alessandro Sette, Daniela Weiskopf · 2016 · Frontiers in Immunology
  35. M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection
    Dubravka Grdic Eliasson, Ajibola Omokanye, Karin Schön, Ulf Alexander Wenzel, Valentina Bernasconi, Mats Bemark, Annasaheb B. Kolpe, Karim El Bakkouri, Tine Ysenbaert, Lei Deng et al. · 2017 · Mucosal Immunology
  36. Host susceptibility to severe influenza A virus infection
    Sara Clohisey, John Kenneth Baillie · 2019 · Critical Care
  37. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
    Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada · 2020 · Vaccine
  38. Harnessing CD4+ T cell responses in HIV vaccine development
    Hendrik Streeck, M. Patricia D’Souza, Dan R. Littman, Shane Crotty · 2013 · Nature Medicine
  39. H5N1 vaccines in humans
    Mariana Baz, Catherine J. Luke, Xing Cheng, Hong Jin, Kanta Subbarao · 2013 · Virus Research
  40. Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens
    Nathalie Landry, Stéphane Pillet, David Favre, Jean‐François Poulin, Sonia Trépanier, Bader Yassine‐Diab, Brian J. Ward · 2014 · Clinical Immunology
  41. Memory CD4 T Cells in Influenza
    Kyra D. Zens, Donna L. Färber · 2014 · Current topics in microbiology and immunology
  42. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly
    Derhovanessian, Evelyna, Maier, Andrea B, Hähnel, Karin, McElhaney, Janet E, Slagboom, Eline P, Pawelec, Graham · 2014 · The Journal of Immunology
  43. Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells
    Linda S. Cauley, Leo Lefrançois · 2012 · Mucosal Immunology
  44. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
    Cynthia Calzas, Christophe Chevalier · 2019 · Frontiers in Immunology
  45. Covid-19: Do many people have pre-existing immunity?
    Peter Doshi · 2020 · BMJ
  46. Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection
    Asher Maroof, Yvonne M. Yorgensen, Yufeng Li, Jay T. Evans · 2014 · PLoS Pathogens
  47. Role of T cell immunity in recovery from influenza virus infection
    Jie Sun, Thomas J. Braciale · 2013 · Current Opinion in Virology
  48. The Effector T Cell Response to Influenza Infection
    Matthew M. Hufford, Taeg S. Kim, Jie Sun, Thomas J. Braciale · 2014 · Current topics in microbiology and immunology
  49. Progress towards the Development of a Universal Influenza Vaccine
    Wen-Chien Wang, Ekramy E. Sayedahmed, Suryaprakash R. Sambhara, Suresh K. Mittal · 2022 · Viruses
  50. Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
    Jacob Atsmon, Yoseph Caraco, Sagit Ziv-Sefer, Dimitry Shaikevich, Ester Abramov, Inna Volokhov, Svetlana Bruzil, Kirsten Y. Haima, Tanya M. Gottlieb, Tamar Ben-Yedidia · 2014 · Vaccine
  51. Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid Protein
    Nicholas Glanville, Gary R. McLean, Bruno Guy, Valérie Lecouturier, Catherine Berry, Yves Girerd-Chambaz, Christophe Grégoire, Ross P. Walton, Rebecca M. Pearson, Tatiana Kebadze et al. · 2013 · PLoS Pathogens
  52. Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
    Kristin Greve-Isdahl Mohn, Geir Bredholt, Karl Albert Brokstad, Rishi D. Pathirana, Hans Jørgen Aarstad, Camilla Tøndel, Rebecca Jane Cox · 2014 · The Journal of Infectious Diseases
  53. Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial
    Stéphane Pillet, Éric Aubin, Sonia Trépanier, Jean‐François Poulin, Bader Yassine‐Diab, Jan ter Meulen, Brian J. Ward, Nathalie Landry · 2018 · npj Vaccines
  54. The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes
    Yasmina I. M. Serroukh, Chunyan Gu‐Trantien, Baharak Hooshiar Kashani, Matthieu Defrance, Thien‐Phong Vu Manh, Abdulkader Azouz, Aurélie Detavernier, Alice Hoyois, Jishnu Das, Martin Bizet et al. · 2018 · eLife
  55. Challenges in developing a cross-serotype rhinovirus vaccine
    Nicholas Glanville, Sebastian Lennox Johnston · 2015 · Current Opinion in Virology
  56. Influenza Vaccines: Successes and Continuing Challenges
    Tanja Becker, Husni Elbahesh, Leslie A. Reperant, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus · 2021 · The Journal of Infectious Diseases
  57. Evaluation of the Humoral and Cellular Immune Responses Elicited by the Live Attenuated and Inactivated Influenza Vaccines and Their Roles in Heterologous Protection in Ferrets
    Xing Cheng, James R. Zengel, Amorsolo L. Suguitan, Qi Xu, Weijia Wang, Jim J.-C. Lin, Hong Jin · 2013 · The Journal of Infectious Diseases
  58. Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity
    Timothy J. Powell, Jonathan D. Silk, Jane L. Sharps, Ervin Fodor, Alain Townsend · 2012 · Journal of Virology
  59. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus
    Sophie B. Morgan, Johanneke Dinie Hemmink, Emily Porter, Ross Harley, Holly A. Shelton, Mario Aramouni, Helen Everett, Sharon M. Brookes, Michael Bailey, Alain Townsend et al. · 2016 · The Journal of Immunology
  60. Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia
    Susan Johnson, Michael A. Eller, Jeffrey E. Teigler, Sebastien M. Maloveste, Bruce T. Schultz, Damien Z. Soghoian, Richard Lu, Alexander F. Oster, Agnès-Laurence Chenine, Galit Alter et al. · 2015 · Journal of Virology
  61. Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
    Florian Krammer, Jerry P. Weir, Othmar G. Engelhardt, Jacqueline M. Katz, Rebecca Jane Cox · 2019 · Influenza and Other Respiratory Viruses
  62. CD4+ Cytotoxic T cells – Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways
    Teresa Preglej, Wilfried Ellmeier · 2022 · Immunology Letters
  63. Endogenous antigen processing drives the primary CD4+ T cell response to influenza
    Michael A. Miller, Asha Purnima Veerappan Ganesan, Nancy A Luckashenak, Mark Mendonça, Laurence Crane Eisenlohr · 2015 · Nature Medicine
  64. Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model
    Jacqueline McBride, Jeremy J. Lim, Tracy Burgess, Rong Deng, Michael A. Derby, Mauricio Maia, Priscilla Horn, Omer Siddiqui, Daniel M. Sheinson, Haiyin Chen‐Harris et al. · 2017 · Antimicrobial Agents and Chemotherapy
  65. Sex Differences in Older Adults' Immune Responses to Seasonal Influenza Vaccination
    Emily A. Voigt, Inna G. Ovsyannikova, Richard B. Kennedy, Diane E. Grill, Krista M. Goergen, Daniel J. Schaid, Gregory A. Poland · 2019 · Frontiers in Immunology
  66. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus
    Stephanie Ascough, Suzanna Paterson, Christopher Chiu · 2018 · Frontiers in Immunology
  67. CD4+ T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine
    Jennifer Lynn Nayak, Theresa F. Fitzgerald, Katherine A. Richards, Hongmei Yang, John Jay Treanor, Andrea J. Sant · 2012 · The Journal of Infectious Diseases
  68. Multipronged CD 4+ T‐cell effector and memory responses cooperate to provide potent immunity against respiratory virus
    Tara M. Strutt, Karl Kai McKinstry, Nikki B. Marshall, Allen M. Vong, Richard W Dutton, Susan L. Swain · 2013 · Immunological Reviews
  69. Innate and adaptive T cells in influenza disease
    Simone Nüssing, Sneha Ashok Sant, Marios Koutsakos, Kanta Subbarao, Thi H. O. Nguyen, Katherine Kedzierska · 2018 · Frontiers of Medicine
  70. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
    Giulietta Saletti, Thomas H. Gerlach, Janina M. Jansen, Antonia Molle, Husni Elbahesh, Martin Ludlow, Wentao Li, Berend‐Jan Bosch, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan · 2020 · Scientific Reports
  71. Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection
    Merani, Shahzma, Pawelec, Graham, Kuchel, George A., McElhaney, Janet E. · 2017 · Frontiers in Immunology
  72. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
    Elena Mitsi, Mariana O. Diniz, Jesús Reiné, Andrea M. Collins, Ryan Robinson, Angela D. Hyder-Wright, Madlen Farrar, Konstantinos Liatsikos, Josh Hamilton, Onyia Onyema et al. · 2023 · Nature Communications
  73. Immune Responses to Avian Influenza Viruses
    Marios Koutsakos, Katherine Kedzierska, Kanta Subbarao · 2019 · The Journal of Immunology
  74. Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity
    Maximilian Koblischke, M. Traugott, Iris Medits, Felicia S. Spitzer, A. Zoufaly, Lukas Weseslindtner, Cara Simonitsch, T. Seitz, W. Hoepler, E. Puchhammer-Stöckl et al. · 2020 · Frontiers in Medicine
  75. Inactivated and Adjuvanted Influenza Vaccines
    Giuseppe Del Giudice, Rino Rappuoli · 2014 · Current topics in microbiology and immunology
  76. Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining
    Hannes Uchtenhagen, Cliff R. Rims, Gabriele Blahnik, I‐Ting Chow, William W. Kwok, Jane Hoyt Buckner, Eddie A. James · 2016 · Nature Communications
  77. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
    Aneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, Leo Swadling, Gabriele Pollara, Rishi K Gupta, Alice R. Burton, José Afonso Guerra‐Assunção, Annemarie Woolston, Tahel Ronel et al. · 2022 · Cell Reports Medicine
  78. The Transcription Factor Hobit Identifies Human Cytotoxic CD4+ T Cells
    Anna E. Oja, Felipe A. Vieira Braga, Ester B. M. Remmerswaal, Natasja A. M. Kragten, Kirsten M. L. Hertoghs, Jianmin Zuo, Paul A. H. Moss, René A. W. van Lier, Klaas P. J. M. van Gisbergen, Pleun Hombrink · 2017 · Frontiers in Immunology
  79. Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
    Wendy Peters, Jennifer R. Brandl, Jonathan D. Lindbloom, Carlos Martínez, Ciaran D. Scallan, George R. Trager, Debora W. Tingley, Martin L. Kabongo, Sean N. Tucker · 2013 · Vaccine
  80. KLRD1-expressing natural killer cells predict influenza susceptibility
    Erika Bongen, Francesco Vallania, Paul J. Utz, Purvesh Khatri · 2018 · Genome Medicine
  81. Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity
    Margaret A. Myers, Amanda Pfaff Smith, Lindey C. Lane, David J. Moquin, Rosemary Aogo, Stacie Woolard, Paul Glyndwr Thomas, Peter Vogel, Amber M. Smith · 2021 · eLife
  82. Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?
    Faith Hannah Nutter Howard, Amy Kwan, Natalie Winder, Amina Mughal, Cristal Collado‐Rojas, Munitta Muthana · 2022 · Viruses
  83. Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
    Yacine Maringer, Annika Nelde, Sarah M. Schroeder, Juliane Schuhmacher, Sebastian Hörber, Andreas Peter, Julia Karbach, Elke Jäger, Juliane S. Walz · 2022 · Science Immunology
  84. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections
    Geraldine Taylor, Michelle L. Thom, Stefania Capone, Angiolo Pierantoni, Efrain Guzman, Rebecca Herbert, Elisa Scarselli, Federico Napolitano, Alessandro Giuliani, Antonella Folgori et al. · 2015 · Science Translational Medicine
  85. High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection.
    Yan Zhao, Yong-Hong Zhang, Laura Denney, D. Young, T. Powell, Yan-Chun Peng, Ning Li, Hui-Ping Yan, Da-Yan Wang, Y. Shu et al. · 2012 · American Journal of Respiratory and Critical Care Medicine
  86. Lactobacillus plantarum vaccine vector expressing hemagglutinin provides protection against H9N2 challenge infection
    Shaohua Shi, Wentao Yang, Guilian Yang, Xuke Zhang, Yuying Liu, Lijiao Zhang, Li-Ping Ye, Jingtao Hu, Xin Xing, Chong Qi et al. · 2015 · Virus Research
  87. Increased Viral Loads and Exacerbated Innate Host Responses in Aged Macaques Infected with the 2009 Pandemic H1N1 Influenza A Virus
    Laurence Josset, Flora Engelmann, Kristen Haberthur, Sara M. Kelly, Byung S. Park, Yoshi Kawoaka, Adolfo García‐Sastre, Michael G. Katze, Ilhem Messaoudi · 2012 · Journal of Virology
  88. Toward Animal Cell Culture–Based Influenza Vaccine Design: Viral Hemagglutinin N-Glycosylation Markedly Impacts Immunogenicity
    Julia Hütter, Jana Rödig, Dirk W. Höper, Peter H. Seeberger, Udo Reichl, Erdmann Rapp, Bernd Lepenies · 2012 · The Journal of Immunology
  89. The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza Infection
    Deborah M. Brown, Anna T. Lampe, Aspen M. Workman · 2016 · Frontiers in Immunology
  90. Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB/c mice
    I‐Na Lu, Sophie Farinelle, Aurélie Sausy, Claude P. Muller · 2016 · Cellular and Molecular Immunology
  91. Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients
    Thi H. O. Nguyen, Marios Koutsakos, Carolien E. van de Sandt, Jeremy Chase Crawford, Liyen Loh, Sneha Ashok Sant, Ludivine Grzelak, Emma Kaitlynn Allen, Tim Brahm, E. Bridie Clemens et al. · 2021 · Nature Communications
  92. Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology
    Robert C. Mettelman, Aisha Hegab Souquette, Lee-Ann Van de Velde, Kasi Vegesana, Emma Kaitlynn Allen, Christina M. Kackos, Sanja Trifkovic, Jennifer DeBeauchamp, Taylor Leigh Wilson, Deryn G. St. James et al. · 2023 · Nature Immunology
  93. NKG2C/E marks the unique cytotoxic CD4 T cell subset, ThCTL, generated by influenza infection
    Nikki B. Marshall, Allen M. Vong, P. Devarajan, Matthew Brauner, Y. Kuang, Ribhu Nayar, Elizabeth Schutten, Catherine H. Castonguay, L. Berg, S. Nutt et al. · 2016 · Journal of Immunology
  94. Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
    Athena P. Y. Li, Carolyn A. Cohen, Nancy Leung, Vicky J. Fang, Shivaprakash Gangappa, Suryaprakash R. Sambhara, Min Z. Levine, Angela Danielle Iuliano, Ranawaka A. P. M. Perera, Dkm Ip et al. · 2021 · npj Vaccines
  95. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
    Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clément, Geert G Leroux-Roels, Isabel Leroux‐Roels · 2022 · Frontiers in Immunology
  96. Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity
    Karen A. O. Martins, Christopher L. Cooper, Sabrina M. Stronsky, SARAH L.W. NORRIS, Steven A. Kwilas, Jesse T. Steffens, Jacqueline G. Benko, Sean A. Van Tongeren, Sina Bavari · 2015 · EBioMedicine
  97. Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older Individuals
    Qian Qi, Mary Cavanagh, Sabine Le Saux, Lisa E. Wagar, Sally Mackey, Jinyu Hu, Holden Terry Maecker, Gary E. Swan, Mark M. Davis, Cornelia L. Dekker et al. · 2016 · PLoS Pathogens
  98. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets
    Koen van de Ven, Josien Lanfermeijer, Harry van Dijken, Hiromi Muramatsu, Caroline Vilas Boas de Melo, Stefanie Lenz, Florence Peters, Mitchell B. Beattie, Paulo J.C. Lin, José A. Ferreira et al. · 2022 · Science Advances
  99. MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
    Annett Hessel, Helga Savidis-Dacho, Sogué Coulibaly, Daniel Portsmouth, Thomas R. Kreil, Brian A. Crowe, Michael G. Schwendinger, Andreas Pilz, P. Noel Barrett, Falko G. Falkner et al. · 2014 · PLoS ONE
  100. Epitope-based approaches to a universal influenza vaccine
    Tanya M. Gottlieb, Tamar Ben-Yedidia · 2014 · Journal of Autoimmunity